Directory
Portfolio companies.
21,000+ PE-backed.
Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.
Active deals
919
currently held
Exits tracked
338
hand-checked
Sectors covered
1
across the portfolio
Countries covered
35
from every market
1,150 companies matching · Page 15 of 23
Tagworks Pharmaceuticals
Ysios BioFund III
NL
Sector
Biotech
InvestorYsios Capital Partners
Entry
2023
Hold
3yr
Targed
BioDiscovery 6
Sector
Biotech
InvestorAndera Partners
Entry
2022
Hold
4yr
Telomere Therapeutics
Invivo Ventures
Sector
Biotech
InvestorInvivo Partners
Entry
2020
Hold
6yr
Thabor Therapeutics
AFB Fund II
Sector
Biotech
InvestorAdBio Partners
Entry
2021
Hold
5yr
Theolytics
Oxford Science Enterprises Balance Sheet
Sector
Biotech
InvestorOxford Science Enterprises
Entry
2017
Hold
9yr
Tizona Therapeutics
Abingworth Bioventures VI
Sector
Biotech
InvestorAbingworth
Entry
2016
Hold
10yr
TolerogenixX
HTGF II
Sector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2016
Hold
10yr
TQ Therapeutics
HTGF IV
Sector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2024
Hold
2yr
TR1X
Neva First
Sector
Biotech
InvestorNeva SGR
Entry
2022
Hold
4yr
Transcripta Bio
BlueYard Capital Fund II
Sector
Biotech
InvestorBlueYard Capital
Entry
2020
Hold
6yr
Treefrog
Digital 3
Sector
Biotech
InvestorXAnge
Entry
2019
Hold
7yr
TRexBio
SV Life Sciences Fund VI
Sector
Biotech
InvestorSV Health Managers
Entry
2018
Hold
8yr
Tridek-One
AFB Seed-Fund
Sector
Biotech
InvestorAdBio Partners
Entry
2019
Hold
7yr
Triple Bio
Nucleus Capital II
Sector
Biotech
InvestorNucleus Capital
Entry
2026
Hold
0yr
Trishula Therapeutics
Abingworth Bioventures VII
Sector
Biotech
InvestorAbingworth
Entry
2020
Hold
6yr
Triumvira Therapeutics
Leaps by Bayer
Sector
Biotech
InvestorLeaps by Bayer
Entry
2020
Hold
6yr
Twig Bio
Project A Ventures IV
Sector
Biotech
InvestorProject A Ventures
Entry
2023
Hold
3yr
Tyris TX
Columbus Life Sciences Fund III
Sector
Biotech
InvestorColumbus Venture Partners
Entry
2021
Hold
5yr
Valbiotis
ACI (Aquitaine Creation Investissement)
Sector
Biotech
InvestorAquiti Gestion
Entry
2015
Hold
11yr
Valo Therapeutics
Indaco BIO
Sector
Biotech
InvestorIndaco Venture Partners SGR
Entry
2025
Hold
1yr
Van Heron Labs
FoodLabs Fund II
Sector
Biotech
InvestorFoodLabs
Entry
2024
Hold
2yr
Vantage Biosciences
ALSA Ventures European Biotechnology Fund
Sector
Biotech
InvestorALSA Ventures
Entry
2023
Hold
3yr
VascVersa
Co-Fund NI
Sector
Biotech
InvestorClarendon Fund Managers
Entry
2021
Hold
5yr
Ventus Therapeutics
TVM Life Science Ventures
Sector
Biotech
InvestorTVM Capital Life Science
Entry
2020
Hold
6yr
Verdiva Bio
General Atlantic Growth Equity Fund
Sector
Biotech
InvestorGeneral Atlantic
Entry
–
VEROVACCiNES
HTGF III
Sector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2017
Hold
9yr
Violet Therapeutics
Dementia Discovery Fund 2
Sector
Biotech
InvestorSV Health Managers
Entry
2023
Hold
3yr
Vivalyx
TechVision Fonds I
Sector
Biotech
InvestorS-UBG AG Aachen Krefeld Mönchengladbach
Entry
2024
Hold
2yr
VIVEbiotech
Inveready Biotech II
Sector
Biotech
InvestorInveready Asset Management
Entry
2019
Hold
7yr
Vivoryon Therapeutics
bmp Aktiengesellschaft
Sector
Biotech
Investorbmp Ventures AG
Entry
1997
Hold
29yr
Wugen
Abingworth Bioventures 8
Sector
Biotech
InvestorAbingworth
Entry
2021
Hold
5yr
WuXi Biologics
General Atlantic Portfolio
China
Sector
Biotech
InvestorGeneral Atlantic
Entry
–
Wuxi XDC
General Atlantic Growth Equity Fund
China
Sector
Biotech
InvestorGeneral Atlantic
Entry
–
X-Therma
LIFTT
Sector
Biotech
InvestorLIFTT
Entry
2024
Hold
2yr
Zedira
HTGF I
Sector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2007
Hold
19yr
Zentraxa
Elbow Beach Capital
Sector
Biotech
InvestorElbow Beach Investments
Entry
2022
Hold
4yr
DiogenX
Omnes Real Tech 1
Sector
Biotech
InvestorOmnes Capital
Entry
2020
Hold
6yr
Owners
5
Inato
La Maison NextGen
Sector
Biotech
InvestorLa Maison Partners
Entry
2017
Hold
9yr
Owners
5
Insempra
Possible Ventures Fund III
Sector
Biotech
InvestorPossible Ventures
Entry
2020
Hold
6yr
Owners
5
SciRhom
Wellington Partners Life Sciences
Sector
Biotech
InvestorWellington Partners
Entry
2016
Hold
10yr
Owners
5
Abalos Therapeutics
coparion
Sector
Biotech
Investorcoparion
Entry
2019
Hold
7yr
Owners
4
AnaCardio
Novo Holdings Venture Investments
Sector
Biotech
InvestorNovo Holdings
Entry
2021
Hold
5yr
Owners
4
Biomemory
Sorbonne Venture by Audacia
Sector
Biotech
InvestorAudacia
Entry
2024
Hold
2yr
Owners
4
DeepLife
Oscar & Paul Venture Capital Fund I
Sector
Biotech
InvestorOscar & Paul (Beiersdorf Venture Capital)
Entry
2024
Hold
2yr
Owners
4
EVerZom
Cap Innov'Est 2
Sector
Biotech
InvestorCapital Grand Est
Entry
2019
Hold
7yr
Owners
4
Exciva
LifeArc Ventures
Sector
Biotech
InvestorLifeArc
Entry
2019
Hold
7yr
Owners
4
Phagos
Citizen Capital Fund III
Sector
Biotech
InvestorCitizen Capital
Entry
2025
Hold
1yr
Owners
4
SenseUp
Simon Capital Evergreen
Sector
Biotech
InvestorSimon Capital
Entry
2025
Hold
1yr
Owners
4
Tacalyx
Boehringer Ingelheim Venture Fund
Sector
Biotech
InvestorBoehringer Ingelheim Venture Fund
Entry
2019
Hold
7yr
Owners
4
Adcytherix
Angelini Ventures
Sector
Biotech
InvestorAngelini Ventures
Entry
2019
Hold
7yr
Owners
3